XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Millions
Total
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Class A Common Stock, Class B Common Stock and Class C Capital Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2020 $ 4,742   $ 0 $ 5,881   $ (1,139)   $ 0
Beginning Balance (in shares) at Dec. 31, 2020     240,526,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options 98     98        
Issuance of common and capital stock upon exercise of stock options (in shares)     2,524,000          
Vesting of restricted stock units (in shares)     2,305,000          
Restricted stock units withheld for tax liability (in shares)     (1,000)          
Share-based compensation expense 250     250        
Issuance of Class C capital stock in connection with equity offering, net of issuance costs 545     545        
Issuance of Class C capital stock in connection with equity offering, net of issuance costs (in shares)     3,164,000          
Settlement of convertible senior notes 403     403        
Settlement of convertible senior notes (in shares)     6,265,000          
Net loss (267)         (267)    
Other comprehensive loss 0              
Ending Balance at Sep. 30, 2021 5,771   $ 0 7,177   (1,406)   0
Ending Balance (in shares) at Sep. 30, 2021     254,782,000          
Beginning Balance at Jun. 30, 2021 5,644   $ 0 6,721   (1,077)   0
Beginning Balance (in shares) at Jun. 30, 2021     248,863,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options 22     22        
Issuance of common and capital stock upon exercise of stock options (in shares)     533,000          
Vesting of restricted stock units (in shares)     712,000          
Share-based compensation expense 90     90        
Settlement of convertible senior notes 344     344        
Settlement of convertible senior notes (in shares)     4,675,000          
Net loss (329)         (329)    
Other comprehensive loss 0              
Ending Balance at Sep. 30, 2021 5,771   $ 0 7,177   (1,406)   0
Ending Balance (in shares) at Sep. 30, 2021     254,782,000          
Beginning Balance at Dec. 31, 2021 5,341 $ (336) $ 0 7,001 $ (492) (1,667) $ 156 7
Beginning Balance (in shares) at Dec. 31, 2021     250,630,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options $ 44              
Issuance of common and capital stock upon exercise of stock options (in shares) 1,078,000   1,078,000          
Vesting of restricted stock units (in shares)     3,278,000          
Share-based compensation expense $ 374     374        
Repurchases of Class A common stock and Class C capital stock (773)     (773)        
Repurchase of Class A common stock and class c capital stock (in shares)     (17,292,000)          
Net loss (29)           $ (29)  
Other comprehensive loss (26)             (26)
Ending Balance at Sep. 30, 2022 4,595   $ 0 6,154   (1,540)   (19)
Ending Balance (in shares) at Sep. 30, 2022     237,694,000          
Beginning Balance at Jun. 30, 2022 4,667   $ 0 6,167   (1,487)   (13)
Beginning Balance (in shares) at Jun. 30, 2022     241,141,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options 2     2        
Issuance of common and capital stock upon exercise of stock options (in shares)     83,000          
Vesting of restricted stock units (in shares)     1,467,000          
Share-based compensation expense 161     161        
Repurchases of Class A common stock and Class C capital stock (176)     (176)        
Repurchase of Class A common stock and class c capital stock (in shares)     (4,997,000)          
Net loss (53)         (53)    
Other comprehensive loss (6)             (6)
Ending Balance at Sep. 30, 2022 $ 4,595   $ 0 $ 6,154   $ (1,540)   $ (19)
Ending Balance (in shares) at Sep. 30, 2022     237,694,000